Abveris Antibody

Description

• Abveris is a Boston-based company that specializes in fee-for-service discovery of novel murine antibodies for reagent and therapeutic purposes. Abveris applies its proprietary DiversimAb Antibody Discovery Platform to generate large, diverse panels of high-quality full-length monoclonal antibodies with ultra-high epitope specificities. Our DiversimAb antibodies are developed naturally in vivo via engineered enhancements in mechanisms of antigen presentation, immune cell activation, and antibody expression. Most projects can be delivered in 60 days.What is DiversimAb technology?DiversimAb is a proprietary in vivo antibody discovery platform that combines genetically modified mouse technology, enhanced immunization protocols, and high throughput screening options to deliver the new gold standard for discovery of high quality, manufacturable monoclonal antibodies. Abveris DiversimAb mice have engineered enhancements in mechanisms of antigen presentation, immune cell activation, and antibody expression that enables superior epitope coverage to both low homology and high homology sequences. The special genetics of the Abveris mouse, the specialized immunization procedure, and high throughput automation technology allows for fastest-in-industry generation of large panels of IgG antibodies with sub-nanomolar affinities.Advantages of the DiversimAb platform:DiversimAb technology is optimized for delivery of large, diverse panels of high-quality, full length monoclonal antibodies with ultra-high epitope specificities. Generate antibodies to high-homology sequences, low-immunogenic epitopes, or even single amino acid sequence changes. Abveris excels in conformation-specific antibodies, neutralizing antibodies and activating antibodies. Most projects can be delivered in 60 days or less.
• 

  Headquarters:480 Neponset Street Suite 10b, Town Of Canton, Massachusetts, United States

  More
• 

  Phone Number: +1 508-580-6701

• 

  Website: https://www.abverisantibody.com

• 

  Employees:25

• 

  Revenue:$10 - 50M

• 

  Legal Name:Abveris Antibody

• Abveris Antibody's Social Media

  
• Is this data correct?

• |  NAICS Code: 423450  |

  Show More